BOULDER, Colo., Sept. 11, 2025 /PRNewswire/ -- Amplifire, a leader in adaptive learning and workforce development, is sharing best practices
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The rising adoption of genomic sequencing, expanding use of companion diagnostics, and growing
PRAGA, LONDRES y CHICAGO, 11 de septiembre de 2025 /PRNewswire/ -- Zentiva, una compañía farmacéutica líder de genéricos en Europa,
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The rising adoption of genomic sequencing, expanding use of companion diagnostics, and growing
NexGen Health in San Jose has launched a physician-led Cerebrolysin IV Therapy Program, offering advanced neurological support through a personalized
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The rising adoption of genomic sequencing, expanding use of companion diagnostics, and growing
NexGen Health in San Jose has launched a physician-led Cerebrolysin IV Therapy Program, offering advanced neurological support through a personalized
SHANGHAI, Sept. 11, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma") announced that its self-developed novel next-generation KCNQ2/3 potassium
Adani Power received a letter of award on Thursday from MPPMCL, awarding 800 MW additional capacity under 'Greenshoe Option',
Adani Power received a letter of award on Thursday from MPPMCL, awarding 800 MW additional capacity under 'Greenshoe Option',